A Strategic Analysis of Patents for Healthcare Management



Abstract Views
228

Downloads
289

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Dec 27, 2022
Published Apr 15, 2023
10.24018/ejbmr.2023.8.2.1802

Abstract viewed = 228 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Patents related to healthcare management software and hardware have played an essential role in international competition in the healthcare field in recent years. The study aimed to conduct a strategic analysis of patents in healthcare management based on the theory of competitive strategy and expectation. The results can be an essential reference for the patent layout of healthcare-related enterprises and the promotion of the commercial value of patents. The study took the WIPS Global database as the object, adopted the keyword patent retrieval method, as well as retrieved and analysed 1,731,925 patent materials related to software and hardware for global healthcare management from 2012 to 2022. The Description, IP competitiveness, Applicant Ranking, Technical vs Market share, and Activity index of global patent abstracts were analysed. The results show that patents were divided by section as A (The number of human necessities patents is 6864, accounting for 7% of the total patents); B (performing operations & transporting, 8379, 9%); G (physics, 47340, 49%); H (electricity, 27254, 28%). The results can be used as a reference for enterprises to carry out healthcare management patent layouts and promote commercial value.
Keywords: Healthcare Management Patent Analysis Patent Layout Healthcare Industry

Downloads

Download data is not yet available.

References

  1. Blind, K. (2021). An update of challenges and possible solutions related to ICT patents: the perspective of European stakeholders. Technology Analysis & Strategic Management https://doi.org/10.1080/09537325.2021.1979508.
     Google Scholar
  2. Blind, K., Cremers, K., & Mueller, E. (2009). The influence of strategic patenting on companies' patent portfolios. Research Policy, 38(2), 428-436.
     Google Scholar
  3. CEEC (2022). Talent selection e-newsletter. College Entrance Examination Center. Retrieved from: https://www.ceec.edu.tw/xcepaper/cont?xsmsid=0J066588036013658199&qunit=0J066632128429024070&sid=0K160541095959507114.
     Google Scholar
  4. Duguet, E., & Kabla, I. (1998). Appropriation strategy and the motivations to use the patent system in France: an economic analysis at the firm level. Annales d'Économie et de Statistique, 49, 289-327.
     Google Scholar
  5. Einarsdóttir, G., Hansla, A., & Johansson, L. O. (2019). Looking back in order to predict the future: Relative resource assessments and their relationship to future expectations. Nordic Psychology, 71(1), 17-38. https://doi-org.autorpa.lib.lhu.edu.tw/10.1080/19012276.2018.1457452.
     Google Scholar
  6. Hsueh, C. C, & Jheng, Y. T. (2017). To explore the relationship among patent expected value, patent application motivation and patent portfolio: Based on the expectancy theory. Technology Management Monthly, 22(4), 29-56.
     Google Scholar
  7. Intellectual Property Office (2022). International classification of patents. Retrieved from: https://topic.tipo.gov.tw/patents-tw/cp-783-872628-6df57-101.html.
     Google Scholar
  8. Lin, H., Li, Y., Li, C., Li, J., & Zou, C. (2008). Patent analysis on the development trend of the agricultural biotechnology industry in various countries. Journal of the Agricultural Association of Taiwan, 9(1), 57-72.
     Google Scholar
  9. Martin, D. K., Vicente, O., Beccari, T., Kellermayer, M., Koller, M., Lal, R., Marks, R. S., Marova, I., Mechler, A., Tapaloaga, D., Žnidaršič-Plazl, P., & Dundar, M. (2021). A brief overview of global biotechnology. Biotechnology & Biotechnological Equipment, 35(1), 5-14, https://doi.org/10.1080/13102818.2021.1878933.
     Google Scholar
  10. Nienke de Graeff, Léon E. Dijkman, Karin R. Jongsma & AnnelienL. Bredenoord (2018). Fair governance of biotechnology: Patents, private governance, and procedural justice, The American Journal of Bioethics, 18(12), 57-59, https: //doi.org/10.1080/15265161.2018.1531176.
     Google Scholar
  11. Olubajo, L., Dimitri, P., Johnston, A., & Owens, M. (2022). Managing inter-organisational collaborations to develop medical technologies: the contribution of interpersonal relationships, Journal of Medical Engineering & Technology, 46(6), 482-496, https://doi. org/10.1080/03091902.2022.2089255.
     Google Scholar
  12. Pearce II, J. A., & Robinson, Jr., R. B. (2005). Formulation, implementation, and control of competitive strategy. New York: McGraw-Hill Irwin.
     Google Scholar
  13. Porter, M. E. (1997). Competitive strategy. Measuring business excellence, 1(2), 12-17. https://doi.org/10.1108/eb025476.
     Google Scholar
  14. Qiu, L., Xu, D., Zhuang, D., & Xu, Z. (2011). Research on the employability of graduates in department-based courses—taking the Department of Medical Management as an example. Journal of Meiho University, 30(1), 93-107.
     Google Scholar
  15. Ramadhani, G. A. N., Astuti, M., & Nasirun, N. (2022). The influence of compatibility and Technology Acceptance Model toward intention to use E-wallet during Covid-19. European Journal of Business and Management Research, 7(5), 148-154. DOI: http://dx.doi.org/10.24018/ ejbmr.2022.7.5.1585.
     Google Scholar
  16. Spekman, R. E., & Isabella, L. A. (2000). Alliance competence: Maximizing the value of your partnerships. New York: John Wiley & Sons, Inc.
     Google Scholar
  17. Xiong, X., Zhu, B., Zeng, Y., & Wang, R. (2009). A study on the driving factors of intangible assets value-Take Taiwan's biochemical technology industry as an example. Determinants of the valuation of intangible assets—An empirical study on the biotech industry. The Journal of Evaluation, 1, 29-43. http://dx.doi.org/10.30073/JV.200905.0003.
     Google Scholar
  18. Xue, L., Zhong, P., & Huang, Y. (2020). Smart medical patent technology analysis. Intellectual Property Monthly, 258, 62-94.
     Google Scholar
  19. Yeh, K. B., Du, E., Olinger., G., & Boston, D. (2022). Biotechnology and biodefense enterprise: An industry perspective on defence acquisition, global security. Health, science and policy, 7(1), 37-43, https:// doi.org/10.1080/23779497.2022.2102527.
     Google Scholar
  20. Zhang, J., & Guan, Z. (2022). IPC or CPC? Comparison and analysis of US patent classification systems. Retried from http://www.maxkuan.tw/lib/exe/fetch.php?media=c13.pdf.
     Google Scholar